Skip to content

Early Versus Standard Endoscopic Interventions for Peripancreatic Fluid Collections

Postponed or Early Drainage of Peripancreatic Fluid Collections: a Randomized Controlled Multicenter Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05281458
Enrollment
60
Registered
2022-03-16
Start date
2021-09-15
Completion date
2024-12-31
Last updated
2023-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis, Endoscopic Ultrasound-Guided Drainage, Pancreatic Fluid Collections, Peripancreatic Fluid Collections

Keywords

Acute Pancreatitis, Peripancreatic Fluid Collections, Endoscopic Ultrasound, Endoscopic Drainage

Brief summary

Acute pancreatitis is a complex gastrointestinal disease with a variable course that is often difficult to predict early in its development. The majority of cases are mild, self-limited, and follow an uncomplicated course. However, 10-20% of cases can be associated with pancreatic or peripancreatic fluid collections, or both. Infected necrosis complicates 10% of all acute pancreatitis episodes and is associated with a mortality of 15-20%. Current guidelines for necrotizing pancreatitis recommend to postpone drainage until 4 or more weeks after initial presentation to allow collections to walled-off. However, evidence of infection with clinical deterioration despite maximum support may mandate earlier intervention. It is unclear whether such delay is needed for drainage or whether earlier endoscopic intervention could actually be beneficial in the current approach. The aims of this randomized, controlled, multicenter study is to evaluate whether early endoscopic drainage in patients with peripancreatic fluid collection is superior to postponed intervention in the current practice.

Detailed description

EUS guided drainage is now the preferred route for peripancreatic fluid collections (PFC). It belongs to transmural drainage and is accomplished by creating a fistula and placing a stent between the gastric or duodenal lumen and the PFC. The size of the PFC and percentage of solid debris were noted prior to puncture, and the optimal site of transluminal puncture was identified using EUS. Participants will be randomly allocated to either the intervention or the control group. Participants in the intervention group will undergo EUS guided drainage earlier (≤1 weeks) in the disease course. The follow-up duration is 6 months from randomization. All patients undergo imaging (contrast enhanced computed tomography) at 3- and 6-months post randomization.

Interventions

PROCEDUREEarly drainage of peripancreatic fluid collections

Participants will undergo EUS guided drainage earlier (≤1 weeks) in the disease course.

Sponsors

Second Affiliated Hospital of Soochow University
CollaboratorOTHER
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
CollaboratorOTHER
Ruijin Hospital
CollaboratorOTHER
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients with PFC; * All patients with PFC will be screened for eligibility including a protocolized approach; * Patients admitted within 72 hours of onset

Exclusion criteria

* More than 30 days after onset of acute pancreatitis * Pregnant women * Documented chronic pancreatitis * Inability to gave informed consent

Design outcomes

Primary

MeasureTime frameDescription
Changes in the Bedside Index of Severe Acute Pancreatitis (BISAP)1-4 weekComparison of BISAP changes between the two groups after different treatments. Also compare the number of participants with BISAP ≥3. BISAP was designed as a predictor of mortality based on 5 variables: blood urea nitrogen (BUN) level greater than 25 mg/dL, impaired mental status, systemic inflammatory response syndrome (SIRS), age older than 60 years, or radiographic evidence of pleural effusion within the first 24 hours of admission. A BISAP score of 3 or greater was associated with developing organ failure, and a higher scores mean a worse outcome.
Number of Participants with New-onset multi-organ failure after intervention1-4 week

Secondary

MeasureTime frame
Rates of mortality6 months
Length of hospital stay3 months
Length of ICU staysup to 3 months
Related complications1 month

Countries

China

Contacts

Primary ContactBaiwen Li
muzibowen@126.com(+86)021-37798977
Backup ContactKui Peng
drpeng@alumni.sjtu.edu.cn(+86)021-37798977

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026